These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 31286523)
1. Local recurrence of Ewing sarcoma: Is wide excision an acceptable treatment? Xue R; Lewis VO; Moon BS; Lin PP J Surg Oncol; 2019 Sep; 120(4):746-752. PubMed ID: 31286523 [TBL] [Abstract][Full Text] [Related]
2. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Stahl M; Ranft A; Paulussen M; Bölling T; Vieth V; Bielack S; Görtitz I; Braun-Munzinger G; Hardes J; Jürgens H; Dirksen U Pediatr Blood Cancer; 2011 Oct; 57(4):549-53. PubMed ID: 21442722 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182 [TBL] [Abstract][Full Text] [Related]
4. Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base. Kharod SM; Indelicato DJ; Rotondo RL; Mailhot Vega RB; Uezono H; Morris CG; Bradfield S; Sandler ES; Bradley JA Pediatr Blood Cancer; 2020 Feb; 67(2):e28080. PubMed ID: 31736243 [TBL] [Abstract][Full Text] [Related]
5. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage? Heinemann M; Ranft A; Langer T; Jürgens H; Kreyer J; Vieth V; Schäfers M; Weckesser M; Simon T; Hassenpflug W; Corbacioglu S; Bielack S; Mayer-Steinacker R; Kühne T; van den Berg H; Gelderblom H; Bauer S; Stegger L; Dirksen U Pediatr Blood Cancer; 2018 Jul; 65(7):e27011. PubMed ID: 29480574 [TBL] [Abstract][Full Text] [Related]
6. Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution's Experience Over 40 Years. Kharod SM; Spiguel AR; Lagmay JP; Jones C; Morris CG; Gibbs CP; Zlotecki RA Am J Clin Oncol; 2019 May; 42(5):421-425. PubMed ID: 30883389 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822 [TBL] [Abstract][Full Text] [Related]
8. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. Wunder JS; Paulian G; Huvos AG; Heller G; Meyers PA; Healey JH J Bone Joint Surg Am; 1998 Jul; 80(7):1020-33. PubMed ID: 9698007 [TBL] [Abstract][Full Text] [Related]
10. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma. Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Lin PP; Jaffe N; Herzog CE; Costelloe CM; Deavers MT; Kelly JS; Patel SR; Madewell JE; Lewis VO; Cannon CP; Benjamin RS; Yasko AW Cancer; 2007 Feb; 109(3):603-11. PubMed ID: 17177205 [TBL] [Abstract][Full Text] [Related]
12. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology. Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567 [TBL] [Abstract][Full Text] [Related]
13. Clinical Features and Long-Term Outcome of Primary Intracranial Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors: 14 Cases From a Single Institution. Chen J; Jiang Q; Zhang Y; Yu Y; Zheng Y; Chen J; Zhao Y; Miao Z; Fan F; Wang Y World Neurosurg; 2019 Feb; 122():e1606-e1614. PubMed ID: 30496933 [TBL] [Abstract][Full Text] [Related]
14. Timing of surgery and the role of adjuvant radiotherapy in ewing sarcoma of the chest wall: a single-institution experience. Denbo JW; Shannon Orr W; Wu Y; Wu J; Billups CA; Navid F; Rao BN; Davidoff AM; Krasin MJ Ann Surg Oncol; 2012 Nov; 19(12):3809-15. PubMed ID: 22752372 [TBL] [Abstract][Full Text] [Related]
15. Pelvic Ewing sarcoma: Should all patients receive pre-operative radiotherapy, or should it be delivered selectively? Lex JR; Kurisunkal V; Kaneuchi Y; Fujiwara T; Sherriff J; Wigley C; Stevenson JD; Parry MC; Jeys LM Eur J Surg Oncol; 2021 Oct; 47(10):2618-2626. PubMed ID: 34030919 [TBL] [Abstract][Full Text] [Related]
16. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy. Devadas SK; Banavali S Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978 [TBL] [Abstract][Full Text] [Related]